» Articles » PMID: 30143010

Challenges and Dilemmas on Universal Coverage for Non-communicable Diseases in Middle-income Countries: Evidence and Lessons from Mexico

Overview
Journal Global Health
Publisher Biomed Central
Date 2018 Aug 26
PMID 30143010
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite more than 20 years of reform projects in health systems, the universal coverage strategy has not reached the expected results in most middle-income countries (MICs). Using evidence from the Mexican case on diabetes and hypertension as tracers of non-communicable diseases, the effective coverage rate barely surpasses half of the expected goals necessary to meet the challenges that these two diseases represent at the population level. Prevalence and incidence rates do not diminish either; they even grow. In terms of the economic burden, this means that lack of financial protection and catastrophic expense rates have increased, contrary to what could have been expected.

Discussion: As any complex system, health systems present challenges and dilemmas that are difficult to solve. In terms of universal coverage, when contrasting normative coverage versus effective coverage, the epidemiological, cultural, organizational and economic challenges and barriers become evident. Such challenges have not allowed a greater effectiveness of the contributions of state of the art medicine in the resolution of health problems, particularly in relation to diabetes and hypertension.

Conclusions: Despite of the existence of many universal coverage projects, strategies and programs implemented in MICs, challenges remain and, far from disappearing, unresolved problems are still present, even with increasing trends. The model of care based on a curative biomedical approach was enough to respond to the health needs of the last century, but is no longer adapted to the needs of the present century. The dilemmas of continuity vs. rupture require to review and discuss the background and structure of health systems and their underlying models of care. These two elements have not allowed the different coverage schemes to guarantee greater effectiveness in the application of state of the art medicine, nor a greater health care financial protection for patients and their families. We thus can either accept the fragmented health systems and bio-medical-curative models of care approach or, instead, we can move towards integrated health systems that would be based on a socio-medical-preventive approach to health care.

Citing Articles

Health beliefs mediates the association between the number of non-communicable diseases and preventive behaviors in middle-aged and older adults in southern China.

Huang Y, Wang T, Wang H, Zeng Y, Xie L Aging Clin Exp Res. 2025; 37(1):49.

PMID: 39994128 PMC: 11850486. DOI: 10.1007/s40520-025-02939-3.


MIDO COVID: A digital public health strategy designed to tackle chronic disease and the COVID-19 pandemic in Mexico.

Gallardo-Rincon H, Gascon J, Martinez-Juarez L, Montoya A, Saucedo-Martinez R, Rosales R PLoS One. 2022; 17(11):e0277014.

PMID: 36395257 PMC: 9671410. DOI: 10.1371/journal.pone.0277014.


Evidence for an expanded hypertension care cascade in low- and middle-income countries: a scoping review.

Peters M, Noonan C, Rao K, Edward A, Alonge O BMC Health Serv Res. 2022; 22(1):827.

PMID: 35761254 PMC: 9235242. DOI: 10.1186/s12913-022-08190-0.


Management of hypertension and dyslipidemia in Mexico: Evidence, gaps, and approach.

Morales-Villegas E, Yarleque C, Almeida M Arch Cardiol Mex. 2022; 93(1):077-087.

PMID: 35359036 PMC: 10161831. DOI: 10.24875/ACM.21000330.


Trends and age-period-cohort effects on hypertension mortality rates from 1998 to 2018 in Mexico.

Castro-Porras L, Rojas-Martinez R, Aguilar-Salinas C, Bello-Chavolla O, Becerril-Gutierrez C, Escamilla-Nunez C Sci Rep. 2021; 11(1):17553.

PMID: 34475436 PMC: 8413460. DOI: 10.1038/s41598-021-96175-0.


References
1.
Bennett S, Ozawa S, Rao K . Which path to universal health coverage? Perspectives on the World Health Report 2010. PLoS Med. 2010; 7(11):e1001001. PMC: 2988776. DOI: 10.1371/journal.pmed.1001001. View

2.
Arredondo A, Aviles R . Costs and epidemiological changes of chronic diseases: implications and challenges for health systems. PLoS One. 2015; 10(3):e0118611. PMC: 4364072. DOI: 10.1371/journal.pone.0118611. View

3.
. Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care. 2018; 41(8):1696-1706. PMC: 6054493. DOI: 10.2337/dc18-0244. View

4.
Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J . Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87(3):293-301. DOI: 10.1016/j.diabres.2010.01.026. View

5.
Barzansky B . Abraham Flexner and the era of medical education reform. Acad Med. 2010; 85(9 Suppl):S19-25. DOI: 10.1097/ACM.0b013e3181f12bd1. View